__timestamp | Alnylam Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 190249000 | 23138050 |
Thursday, January 1, 2015 | 276495000 | 57410147 |
Friday, January 1, 2016 | 382392000 | 41454452 |
Sunday, January 1, 2017 | 390635000 | 31690298 |
Monday, January 1, 2018 | 505420000 | 52968505 |
Tuesday, January 1, 2019 | 655114000 | 81048686 |
Wednesday, January 1, 2020 | 654819000 | 128874979 |
Friday, January 1, 2021 | 792156000 | 206342000 |
Saturday, January 1, 2022 | 883015000 | 297307000 |
Sunday, January 1, 2023 | 1004415000 | 353188000 |
Monday, January 1, 2024 | 1126232000 | 505870000 |
Cracking the code
In the competitive world of biopharmaceuticals, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Alnylam Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated significant commitment to R&D, albeit at different scales. Alnylam's R&D expenses have surged by over 400% from 2014 to 2023, reflecting its aggressive pursuit of cutting-edge therapies. In contrast, Arrowhead has shown a remarkable 1,400% increase in the same period, albeit from a smaller base, highlighting its rapid growth trajectory.
The data for 2024 is incomplete, suggesting ongoing developments in both companies' R&D strategies.
Comparing Innovation Spending: AbbVie Inc. and Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs BeiGene, Ltd.
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Axsome Therapeutics, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Biogen Inc. and Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Insmed Incorporated and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Alkermes plc vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.